Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Invested Capital (2020 - 2026)

NeuroPace has reported Invested Capital over the past 7 years, most recently at $73.5 million for Q1 2026.

  • For Q1 2026, Invested Capital fell 12.59% year-over-year to $73.5 million; the TTM value through Mar 2026 reached $73.5 million, down 12.59%, while the annual FY2025 figure was $77.9 million, 15.36% up from the prior year.
  • Invested Capital for Q1 2026 was $73.5 million at NeuroPace, down from $77.9 million in the prior quarter.
  • Over five years, Invested Capital peaked at $112.9 million in Q1 2022 and troughed at $67.5 million in Q4 2024.
  • A 5-year average of $80.9 million and a median of $77.6 million in 2023 define the central range for Invested Capital.
  • On a YoY basis, Invested Capital climbed as much as 174.13% in 2022 and fell as far as 28.91% in 2022.
  • Year by year, Invested Capital stood at $87.7 million in 2022, then decreased by 11.5% to $77.6 million in 2023, then decreased by 12.98% to $67.5 million in 2024, then grew by 15.36% to $77.9 million in 2025, then decreased by 5.7% to $73.5 million in 2026.
  • Business Quant data shows Invested Capital for NPCE at $73.5 million in Q1 2026, $77.9 million in Q4 2025, and $77.3 million in Q3 2025.